Novartis Aktie
100,20
EUR
+1,14
EUR
+1,15
%
93,50
CHF
+1,35
CHF
+1,47
%
Werbung
Novartis Aktie Analyse
25.01.17 | Novartis buy | Baader Bank | |
24.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
19.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
16.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
09.01.17 | Novartis Hold | Deutsche Bank AG | |
03.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
19.12.16 | Novartis buy | Jefferies & Company Inc. | |
Werbung
|
|||
13.12.16 | Novartis Hold | Deutsche Bank AG | |
13.12.16 | Novartis overweight | JP Morgan Chase & Co. | |
13.12.16 | Novartis buy | HSBC | |
08.12.16 | Novartis Neutral | UBS AG | |
30.11.16 | Novartis Hold | Deutsche Bank AG | |
18.11.16 | Novartis overweight | JP Morgan Chase & Co. | |
08.11.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
31.10.16 | Novartis buy | Baader Wertpapierhandelsbank | |
26.10.16 | Novartis Outperform | Credit Suisse Group | |
26.10.16 | Novartis Hold | Deutsche Bank AG | |
26.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
25.10.16 | Novartis Hold | S&P Capital IQ | |
24.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
19.10.16 | Novartis Outperform | Bernstein Research | |
19.10.16 | Novartis Underweight | Morgan Stanley | |
19.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
14.10.16 | Novartis Hold | Deutsche Bank AG | |
13.10.16 | Novartis buy | Jefferies & Company Inc. | |
10.10.16 | Novartis Hold | Deutsche Bank AG | |
10.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
10.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
14.09.16 | Novartis Neutral | BNP PARIBAS | |
13.09.16 | Novartis overweight | JP Morgan Chase & Co. | |
11.08.16 | Novartis buy | Kepler Cheuvreux | |
04.08.16 | Novartis buy | Jefferies & Company Inc. | |
04.08.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
21.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
20.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
20.07.16 | Novartis Outperform | Bernstein Research | |
20.07.16 | Novartis Neutral | UBS AG | |
20.07.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
19.07.16 | Novartis Halten | Independent Research GmbH | |
18.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
14.07.16 | Novartis buy | Jefferies & Company Inc. | |
13.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
12.07.16 | Novartis Underweight | Morgan Stanley | |
07.07.16 | Novartis buy | Kepler Cheuvreux | |
06.07.16 | Novartis Halten | Independent Research GmbH | |
23.06.16 | Novartis Hold | Deutsche Bank AG | |
31.05.16 | Novartis Underweight | Morgan Stanley | |
26.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
23.05.16 | Novartis overweight | JP Morgan Chase & Co. |
Werbung
Werbung